Yoshiharu Iwabuchi

This inventor holds 5 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Tohoku University, Brain Innovation Co., Inc.. Active years: 2014-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoshiharu Iwabuchi. Retrieved from https://idiyas.com/inventor/yoshiharu-iwabuchi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 5 (Patent Applications = 2)

% Patents Active = 60.0

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 2.9

ph-index = 1

Forward Citations = 2(Granted Patents)

Company Filing History:

Brain Innovation Co., Inc.

patent

where one patent can have more than one assignee

Years Active: 2014-2024

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11912688 - 1, 3-dioxolane derivative (2024-02-27),

2. 11608313 - Adamantylmethylamine derivative and use thereof as pharmaceutical (2023-03-21),

3. 10487045 - Adamantane derivative and use thereof (2019-11-26),

4. 9114390 - 9-azanoradamantane N—oxyl compound and method for producing same, and organic oxidation catalyst and method for oxidizing alcohols using 9-azanoradamantane N—oxyl compound (2015-08-25),

5. 8871981 - Method for oxidizing alcohols (2014-10-28),

Title: The Innovations of Yoshiharu Iwabuchi

Introduction

Yoshiharu Iwabuchi is a notable inventor based in Miyagi, Japan. He has made significant contributions to the field of pharmaceuticals, holding a total of 5 patents. His work focuses on developing compounds that have potential therapeutic applications.

Latest Patents

Among his latest patents, Iwabuchi has developed a 1,3-dioxolane derivative. This invention provides a compound represented by a specific chemical formula or a pharmaceutically acceptable salt thereof, along with a pharmaceutical composition containing the same. Another significant patent is for an adamantylmethylamine derivative, which is aimed at treating or preventing cognitive diseases or disorders. This pharmaceutical composition comprises a compound represented by a specific formula, including its enantiomer or diastereomer, or a pharmaceutically acceptable salt thereof.

Career Highlights

Yoshiharu Iwabuchi has worked with esteemed institutions such as Tohoku University and Brain Innovation Co., Inc. His research and innovations have contributed to advancements in the pharmaceutical industry, particularly in cognitive health.

Collaborations

Iwabuchi has collaborated with notable colleagues, including Shigeki Moriguchi and Koji Fukunaga. Their combined expertise has furthered the development of innovative pharmaceutical solutions.

Conclusion

Yoshiharu Iwabuchi's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to impact the development of treatments for cognitive disorders.

Profile summary based on public USPTO records.